Marban E, Robinson S W, Wier W G
J Clin Invest. 1986 Nov;78(5):1185-92. doi: 10.1172/JCI112701.
Drug-induced triggered arrhythmias in heart muscle involve oscillations of membrane potential known as delayed or early afterdepolarizations (DADs or EADs). We examined the mechanism of DADs and EADs in ferret ventricular muscle. Membrane potential, tension and aequorin luminescence were measured during exposure to elevated [Ca2+]0, strophanthidin and/or isoproterenol (to induce DADs), or cesium chloride (to induce EADs). Ryanodine (10(-9)-10(-6) M), an inhibitor of Ca2+ release from the sarcoplasmic reticulum, rapidly suppressed DADs and triggered arrhythmias. When cytoplasmic Ca2+-buffering capacity was enhanced by loading cells with the Ca2+ chelators BAPTA or quin2, DADs were similarly inhibited, as were contractile force and aequorin luminescence. In contrast to DADs, EADs induced by Cs were not suppressed by ryanodine or by loading with intracellular Ca2+ chelators. The possibility that transsarcolemmal Ca2+ entry might produce EADs was evaluated with highly specific dihydropyridine Ca channel agonists and antagonists. Bay K8644 (100-300 nM) potentiated EADs, whereas nitrendipine (3-20 microM) abolished EADs. We conclude that DADs and DAD-related triggered arrhythmias are activated by an increase in intracellular free Ca2+ concentration, whereas EADs do not require elevated [Ca2+]i but rather arise as a direct consequence of Ca2+ entry through sarcolemmal slow Ca channels.
药物诱发的心肌触发心律失常涉及膜电位振荡,即延迟或早期后去极化(DADs或EADs)。我们研究了雪貂心室肌中DADs和EADs的机制。在暴露于升高的[Ca2+]0、毒毛花苷和/或异丙肾上腺素(以诱发DADs)或氯化铯(以诱发EADs)期间,测量膜电位、张力和水母发光蛋白发光。ryanodine(10^(-9)-10^(-6) M),一种肌浆网Ca2+释放抑制剂,迅速抑制DADs和触发的心律失常。当通过用Ca2+螯合剂BAPTA或quin2加载细胞来增强细胞质Ca2+缓冲能力时,DADs同样受到抑制,收缩力和水母发光蛋白发光也受到抑制。与DADs不同,Cs诱导的EADs不受ryanodine或加载细胞内Ca2+螯合剂的抑制。用高度特异性的二氢吡啶Ca通道激动剂和拮抗剂评估跨肌膜Ca2+内流可能产生EADs的可能性。Bay K8644(100-300 nM)增强EADs,而尼群地平(3-20 microM)消除EADs。我们得出结论,DADs和与DAD相关触发的心律失常是由细胞内游离Ca2+浓度增加激活的,而EADs不需要升高的[Ca2+]i,而是作为Ca2+通过肌膜慢Ca通道内流的直接结果出现。